CIHR Operating Grant: Addressing the Wider Health Impacts of COVID-19
Launched in early September, this funding opportunity seeks research proposals to address the gaps in knowledge about the wider impacts of the COVID-19 pandemic and response on the health and health care of people in Canada. Suspension/interruption of cancer screening is one of the research areas of focus.
The maximum amount per grant that can be requested for clinical trial research is $1,000,000 over 2 years; for other types of research, the maximum amount per grant is $500,000 over 2 years. Registration deadline is October 18, 2021. For more information, see https://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=3548&language=E.
COVID-19 and the Future of Our Health Research and Innovation System
Life Sciences Ontario, in collaboration with Shift Health, is convening an online session, “COVID-19 and the Future of Our Health Research and Innovation System” on May 28 from 3:00 to 4:30 pm EDT. Speakers include: Dr. Jim Tartaglia, Vice-President R&D, Global Head of ... Read More »
Life Sciences Ontario, in collaboration with Shift Health, is convening an online session, “COVID-19 and the Future of Our Health Research and Innovation System” on May 28 from 3:00 to 4:30 pm EDT. Speakers include: Dr. Jim Tartaglia, Vice-President R&D, Global Head of ... Read More »
Top 10 Cancer Research Priorities for AYA
Over the last 2 years, Dr. Perri Tutelman, Chantale Thurston, and Dr. Fiona Schulte, in collaboration with the James Lind Alliance (JLA), worked with the adolescent and young adult cancer (AYA) community to establish what research topics matter most to patients, their loved ones, and clinician... Read More »
Over the last 2 years, Dr. Perri Tutelman, Chantale Thurston, and Dr. Fiona Schulte, in collaboration with the James Lind Alliance (JLA), worked with the adolescent and young adult cancer (AYA) community to establish what research topics matter most to patients, their loved ones, and clinician... Read More »